Where you live in Britain influences both your risk of developing lung disease as well as your survival chances. Pulmonary fibrosis is a telling example of this inequality - people living in the most
Stanford geneticist Gary Peltz uses Co-Scientist to identify drug-repurposing candidates that could lead to new treatments for chronic liver disease and fibrosis
